Table 1 Selected genes with high/moderate and low or unknown cancer predisposition in alphabetical order, autosomal dominant first, followed by autosomal recessive and X-linked transmission.

From: Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels

Gene name

Location hg19

Gene MIM no.

Tumour Types(Germline)

Cancer Syndrome

Inheri-tance

ACMG recomm.

High risk genes with established predictions with surveillance recommendations

APC

5q22.2

611731

colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS

adenomatous polyposis coli; Turcot syndrome

AD

yes

BMPR1A

10q23.2

601299

gastrointestinal polyps

juvenile polyposis

AD

yes

BRCA1

17q21.31

113705

breast, ovarian

hereditary breast/ovarian cancer

AD

yes

BRCA2

13q13.1

600185

breast, ovarian, pancreatic, leukaemia

hereditary breast/ovarian cancer

AD

yes

CDH1

16q22.1

192090

gastric

familial gastric carcinoma

AD

no

CDK4

12q14.1

123829

melanoma

familial malignant melanoma

AD

no

CDKN2A

9p21.3

600160

melanoma, pancreatic

familial malignant melanoma

AD

no

EPCAM

2p21

185535

colorectal

Colorectal cancer, hereditary nonpolyposis, type 8

AD

no

FH

1q43

136850

leiomyomatosis, renal

hereditary leiomyomatosis and renal cell cancer

AD

no

FLCN

17p11.2

607273

renal, fibrofolliculomas, trichodiscomas

Birt-Hogg-Dube syndrome

AD

no

MEN1

11q13.1

613733

parathyroid adenoma, pituitary adenoma, pancreatic islet cell, carcinoid

multiple endocrine neoplasia type 1

AD

yes

MLH1

3p22.2

120436

colorectal, endometrial, ovarian, central nervous system

hereditary non-polyposis colorectal cancer, Turcot syndrome

AD

yes

MSH2

2p21-p16

609309

colorectal, endometrial, ovarian

hereditary non-polyposis colorectal cancer

AD

yes

MSH6

2p16.3

600678

colorectal, endometrial, ovarian

hereditary non-polyposis colorectal cancer

AD

yes

MUTYH

1p34.1

604933

colorectal

adenomatous polyposis coli

AR

yes

NF1

17q11.2

613113

neurofibroma, glioma

neurofibromatosis type 1

AD

no

NF2

22q12.2

607379

meningioma, acoustic neuroma

neurofibromatosis type 2

AD

yes

PMS2

7p22.1

600259

colorectal, endometrial, ovarian, medulloblastoma, glioma

hereditary non-polyposis colorectal cancer, Turcot syndrome

AD

yes

PTCH1

1p34.1

603673

skin basal cell, medulloblastoma

nevoid basal cell carcinoma syndrome

AD

no

PTEN

10q23.31

601728

harmartoma, glioma, prostate, endometrial

Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome

AD

yes

RB1

13q14.2

614041

retinoblastoma, sarcoma, breast, small cell lung carcinoma

familial retinoblastoma

AD

yes

RET

10q11.21

164761

medullary thyroid, papillary thyroid, pheochromocytoma

multiple endocrine neoplasia 2A/2B

AD

yes

SDHB

1p36.13

185470

paraganglioma, pheochromocytoma

familial paraganglioma

AD

yes

SDHD

11q23.1

602690

paraganglioma, pheochromocytoma

familial paraganglioma

AD

yes

SDHAF2

11q12.2

613019

paraganglioma

familial paraganglioma

AD

yes

SDHC

1q23.3

602413

paraganglioma, pheochromocytoma

familial paraganglioma

AD

yes

SMAD4

18q21.2

600993

gastrointestinal polyp

juvenile polyposis

AD

yes

STK11

19p13.3

602216

jejunal hamartoma, ovarian, testicular, pancreatic

Peutz-Jeghers syndrome

AD

yes

TGFBR2

3p24.1

190182

colorectal

Hereditary Nonpolyposis Colorectal Cancer type 6

AD

yes

TP53

17p13.1

191170

breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types

Li-Fraumeni syndrome

AD

yes

TSC1

9q34.13

605284

hamartoma, renal cell carcinoma, tuberous sclerosis tuber

Tuberous sclerosis 1

AD

yes

TSC2

16p13.3

191092

hamartoma, renal cell carcinoma, tuberous sclerosis tuber

Tuberous sclerosis 2

AD

yes

VHL

3p25.3

608537

renal, haemangioma, pheochromocytoma

Von Hippel-Lindau syndrome

AD

yes

WT1

11p13

607102

Wilms tumour

Denys-Drash syndrome, Frasier syndrome, familial Wilms tumour

AD

yes

FANCA

16q24.3

607139

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group A

AR

no

FANCB

Xp22.2

300515

Acute myeloid leukemia, leukaemia

Fanconi anemia, complementation group B

XLR

no

FANCC

9q22.32

613899

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group C

AR

no

FANCD2

3p25.3

613984

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group D2

AR

no

FANCE

6p21.31

613976

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group E

AR

no

FANCF

11p14.3

613897

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group F

AR

no

FANCG

9p13.3

602956

Acute myeloid leukemia, leukaemia

Fanconi anaemia complementation group G

AR

no

FANCL

2p16.1

608111

Acute myeloid leukemia, leukaemia

Fanconi anemia, complementation group L

AR

no

EGFR

7p11.2

131550

Non-small-cell lung carcinoma

familial lung cancer

AR

no

ERCC2

19q13.32

126340

skin basal cell, skin squamous cell, melanoma

Xeroderma pigmentosum, group D

AR

no

ERCC3

2q14.3

133510

skin basal cell, skin squamous cell, melanoma

Xeroderma pigmentosum, group B

AR

no

ERCC4

16p13.12

133520

skin basal cell, skin squamous cell, melanoma

Xeroderma pigmentosum, group F

AR

no

ERCC5

13q33.1

133530

skin basal cell, skin squamous cell, melanoma

Xeroderma pigmentosum, group G

AR

no

EXT1

8q24.11

608177

exostoses, osteosarcoma

multiple exostoses type 1

AR

no

NBN

8q21.3

602667

Non-Hodgkin lymphoma, glioma, medulloblastoma, rhabdomyosarcoma

Nijmegen breakage syndrome

AR

no

Moderate/increased risk genes that are acknowledged guidelines screening and risk reduction measures in accordance with family history

ALK

2p23.2-p23.1

105590

neuroblastoma

familial neuroblastoma

AD

no

ATM

11q22.3

607585

leukaemia, lymphoma, medulloblastoma, glioma

ataxia-telangiectasia

AD

no

BAP1

3p21.1

603089

mesothelioma, uveal melanoma

Tumor predisposition syndrome

AD

no

BRIP1

17q23.2

605882

AML, leukaemia, breast

Fanconi anaemia J, breast cancer susceptiblity

AD

no

CHEK2

22q12.1

604373

breast

familial breast cancer

AD

no

PALB2

16p12.2

610355

Wilms tumour, medulloblastoma, AML, breast

Fanconi anaemia N, breast cancer susceptibility

AD

no

RAD51C

17q22

602774

Breast,ovarian cancer

Breast-ovarian cancer, familial, susceptibility to, 3

AD

no

RAD51D

17q12

602954

Breast,ovarian cancer

Breast-ovarian cancer, familial, susceptibility to, 4

AD

no

Genes that have moderate or high risk based on published studies but pending professional recommendations regarding surveillance and risk reduction strategies

ATR

3q23

601215

oropharyngeal

familial cutaneous telangiectasia and cancer syndrome, Seckel Syndrome

AD

no

AXIN2

17q24.1

604025

colorectal carcinoma

oligodontia-colorectal cancer syndrome

AD

no

BARD1

2q35

601593

ovarian cancer, breast cancer, endometrioid cancer

AD

no

BLM

15q26.1

604610

leukaemia, lymphoma, skin squamous cell, other tumour types

Bloom syndrome

AD

no

CDC73

1q31.2

607393

parathyroid adenoma, multiple ossifying jaw fibroma

hyperparathyroidism-jaw tumour syndrome

AD

no

CDKN1B

12p13.1

600778

pituitary, parathyroid

multiple endocrine neoplasia type IV

AD

no

DICER1

14q32.13

606241

pleuropulmonary blastoma

familial pleuropulmonary blastoma or DICER1 syndrome

AD

no

EXT2

11p11.2

608210

exostoses, osteosarcoma

multiple exostoses type 2

AD

no

GALNT12

9q22.33

610290

colorectal

Colorectal cancer, susceptibility to, 1

AD

no

HNF1A

12q24.31

142410

hepatic adenoma, hepatocellular carcinoma

familial hepatic adenoma

AD

no

HOXB13

17q21-q22

604607

prostate

Prostate cancer, hereditary, 9

AD

no

HRAS

11p15.5

190020

rhabdomyosarcoma, ganglioneuroblastoma, bladder

Costello syndrome

AD

no

KDR

4q12

191306

melanoma

Hemangioma, capillary infantile, susceptibility to

AD

no

KIT

4q12

164920

gastrointestinal, epithelioma

familial gastrointestinal stromal tumour

AD

no

MAX

14q23.3

154950

pheochromocytoma

Pheochromocytoma, susceptibility to

AD

no

MITF

3p13

156845

melanoma

Melanoma, cutaneous malignant, susceptibility to, 8

AD

no

PDGFRA

4q12

173490

gastrointestinal stromal tumour

familial gastrointestinal stromal tumour

AD

no

PHB

17q21.33

176705

Breast cancer

{Breast cancer, susceptibility to}

AD

no

PHOX2B

4p13

603851

neuroblastoma

familial neuroblastoma

AD

no

POLD1

19q13.33

174761

colorectal

Lynch syndrome

AD

no

PRF1

10q22.1

170280

various leukaemia, lymphoma

AD

no

PRKAR1A

17q24.2

188830

myxoma, endocrine, papillary thyroid

Carney complex

AD

no

RAD50

5q31.1

604040

breast cancer

Nijmegen breakage syndrome-like disorder

AR

no

RAD51A

15q15.1

179617

breast cancer

?Fanconi anemia, complementation group R

AD

no

RAD54L

1p34.1

603615

breast cancer

Breast cancer, invasive ductal

AD

no

SDHA

5p15.33

600857

paraganglioma

paragangliomas-5 (PGL5)

AD

no

SMARCB1

22q11.23

601607

malignant rhabdoid

rhabdoid predisposition syndrome

AD

no

SMARCE1

17q21.2

603111

meningioma

Meningioma, familial, susceptibility to

AD

no

TERT

5p15.33

187270

melanoma

Melanoma, cutaneous malignant, 9

AD

no

TMEM127

2q11.2

613403

pheochromocytoma, renal cell carcinoma

Pheochromocytoma, susceptibility to

AD

no

DDB2

11p11.2

600811

skin basal cell, skin squamous cell, melanoma

xeroderma pigmentosum (E)

AR

no

RECQL4

8q24.3

603780

osteosarcoma, skin basal cell, skin sqamous cell

Rothmund-Thompson syndrome

AR

no

XPA

9q22.33

611153

skin basal cell, skin squamous cell, melanoma

xeroderma pigmentosum (A)

AR

no

XPC

3p25.1

613208

skin basal cell, skin squamous cell, melanoma

xeroderma pigmentosum (C)

AR

no

SUFU

10q24.32

607035

medulloblastoma

medulloblastoma predisposition

AR, AD

no

GPC3

Xq26.2

300037

Wilms tumour

Simpson-Golabi-Behmel syndrome

XLR

no

WAS

Xp11.23

300392

lymphoma

Wiskott-Aldrich syndrome

XLR

no